kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports Targeting KRAS-mutant stomach/colorectal tumors by
Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect KRAS Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions PMC The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC What should we know about the 'undruggable' target KRAS? MedChemExpress Targeting KRAS: from metabolic regulation to cancer treatment Molecular Cancer Springer Nature Link Uncovering new therapeutic targets for a common KRAS mutation behind cancer
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





